Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:42:09.621Z.
Consensus retrieved: 2026-10-06T13:18:27.438Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:42:09.621Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0b8025f704655349782d47d219081ed0d317ba91c4dcab760c02f1a4064a70a5
Forward PE Ratio (N/A) = Dated Quote Price ($5.96) / Consensus Forward EPS ($-9.65)
FORWARD PE RATIO
N/A
Kyntra Bio, Inc.
Market Cap
$24.13M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.13M | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 11.88 |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.68M | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $5.96, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-9.65 | $-11.46 – $-7.63 | 2 | n/m |
| 2027-12-31 | $-11.30 | $-14.78 – $-8.33 | 3 | n/m |
| 2028-12-31 | $-11.82 | $-19.54 – $-6.75 | 4 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
